Fundraising Fox
/People
Sign in

Scott Naisbitt

Lutonix · Kauffman Fellow (Class 8)

United States

Kauffman Fellow · Class 8

Find your path to Scott

1,754 people in our graph can introduce you to Scott.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Tom Melzer to introduce you to Scott

You →Tom · together at RiverVest Venture Partners (2002–2008) →Scott

Ask Jamie Chen to introduce you to Scott

You →Jamie · 7 people · together at RiverVest Venture Partners →Scott

Ask Sam Okafor to introduce you to Scott

You →Sam · 2 people · together at Harvard Medical School →Scott

Sign up to find every way you can get introduced to Scott

  • Your email: the people you already email who know Scott
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Scott
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Scott Naisbitt was Vice President of Scientific and Medical Affairs at Lutonix, a subsidiary of CR Bard, having been a founding board member and Chief Scientific Officer prior to the company's acquisition in December 2011, where he led scientific strategy for a drug-device combination product that received the first FDA-approved IDE for a drug-coated balloon. His earlier experience includes roles as a principal and entrepreneur-in-residence at RiverVest Venture Partners and an associate at Seedling Enterprises, along with board memberships at Lutonix Inc. and IDEV Technologies. He holds an MD from the Harvard-MIT Division of Health Sciences and Technology, a PhD from Harvard University, and BS degrees in Physics and Mathematics from the University of Utah, and has conducted research at Harvard Medical School and Massachusetts General Hospital.

Experience

  1. Lutonix, Inc., a subsidiary of CR BardVP Scientific & Medical Affairs2011 — 2015New Hope, MN
  2. Lutonix, Inc.Chief Scientific Officer2008 — 2011Maple Grove, MN
  3. RiverVest Venture PartnersPrincipal and Entrepreneur-in-Residence2002 — 2008St. Louis, MO
  4. Seedling EnterprisesAssociate2001 — 2002Greater Boston Area

Skills & more

LifesciencesVenture CapitalCombination ProductsMedical DevicesBiotechnologyPharmaceutical IndustryClinical ResearchR&DStart-upsEntrepreneurshipDue DiligenceHealthcare
+3 moreResearchNeuroscienceClinical Trials

From Scott's professional profile.

Network1

Mark MendelMentor
Sozo Ventures · Kauffman Fellow (Class 1)

Investors connected to Scott in public investor directories — a warm-intro map.

Frequently asked questions

Who is Scott Naisbitt?
Scott Naisbitt was Vice President of Scientific and Medical Affairs at Lutonix, a subsidiary of CR Bard, having been a founding board member and Chief Scientific Officer prior to the company's acquisition in December 2011, where he led scientific strategy for a drug-device combination product that received the first FDA-approved IDE for a drug-coated balloon. His earlier experience includes roles as a principal and entrepreneur-in-residence at RiverVest Venture Partners and an associate at Seedling Enterprises, along with board memberships at Lutonix Inc. and IDEV Technologies. He holds an MD from the Harvard-MIT Division of Health Sciences and Technology, a PhD from Harvard University, and BS degrees in Physics and Mathematics from the University of Utah, and has conducted research at Harvard Medical School and Massachusetts General Hospital.
Where did Scott Naisbitt go to school?
Scott Naisbitt studied at Harvard Medical School (Doctor of Medicine (MD)); Harvard University (Doctor of Philosophy (Ph.D.), Neuroscience); University of Utah (Bachelor of Science (BS), Mathematics and Physics).

Same school

Shared employers